Paul Armstrong
Postdoctoral Research Fellow
Paul Armstrong is a Lecturer in Pharmacology at Queen Mary University of London (QMUL), specialising in cardiovascular pharmacology and the molecular mechanisms underlying thrombosis. He obtained his BSc Hons in Pharmacology from the University of Edinburgh, and PhD in 2009 under Prof Tim Warner at the William Harvey Research Institute studying the antiplatelet pharmacology of aspirin. Following postdoctoral research studies at the Baker Institute in Melbourne with Prof Karlheinz Peter investigating the thrombotic impact of the secreted S.aureus toxin SSL5, he returned to QMUL to continue his research into the pharmacology of combined antiplatelet therapies on platelets and the vasculature. He was appointed Lecturer in 2020. His research continues to apply functional phenotypic approaches to study the impact of platelet turnover and heterogeneity on thrombotic risk within cardiovascular disease, trauma, inherited bleeding disorders, and inflammation. Paul supports the wider research community as a member of the International Society of Thrombosis and Haemostasis (ISTH) Early Career Committee (2020 – 2025) and Deputy Chair of the Executive Committee of Platelet Society.
